Загрузка...
EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib
Expression of TFAP2C in luminal breast cancer is associated with reduced survival and hormone resistance, partially explained through regulation of RET. TFAP2C also regulates EGFR in HER2 breast cancer. We sought to elucidate the regulation and functional role of EGFR in luminal breast cancer. We us...
Сохранить в:
| Опубликовано в: : | Mol Cancer Ther |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4783288/ https://ncbi.nlm.nih.gov/pubmed/26832794 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0548-T |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|